zuma-5 update: retreatment of r/r inhl with axi-cel
Published 3 years ago • 48 plays • Length 3:46Download video MP4
Download video MP3
Similar videos
-
1:20
axi-cel in r/r fl: an updated comparison of zuma-5 and the scholar-5 external control cohort
-
3:18
zuma-5: axi-cel for r/r inhl
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
4:51
zuma-5: axi-cel for r/r non-hodgkin lymphoma
-
2:19
zuma-3: identifying the optimal dose of axi-cel in r/r all
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
0:54
zuma-3 end of phase i results: axi-cel for r/r all
-
58:23
computational genomics: introduction to r for genomic data analysis (comp_genom01 2)
-
7:29
how to change reagent at horiba yumizen [email protected] #part-4
-
2:10
robust, cost-effective automated 6 part hematology analyzer yumizen h500 at my lab - dr parag dharap
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
2:52
zuma-24 preliminary analysis of axi-cel in the outpatient setting in patients with r/r lbcl
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
1:34
zuma-1 update: safety data of axi-cel in patients with r/r dlbcl
-
1:08
zuma-7: overall survival benefit of axi-cel over soc in second-line lbcl
-
1:39
updates on zuma-7: clinical and patient-reported outcomes in elderly patients with r/r lbcl
-
4:44
zuma-7 subgroup analysis: axi-cel vs soc in elderly patients with r/r lbcl
-
2:32
zuma-1 update: durable survival in r/r dlbcl patients treated with axi-cel
-
2:48
results from a subgroup analysis of zuma-3 and the efficacy of brexu-cel in r/r b-all
-
1:21
approval of axi-cel in second-line for r/r lbcl & label update
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7